Jeffrey A Wesson

Jeffrey A. Wesson, MD, PhD, is an Adjunct Professor at the Medical College of Wisconsin with clinical appointments at Froedtert Hospital and the Zablocki VA Medical Center. His clinical expertise spans nephrology, internal medicine, and kidney stone management. He holds dual doctorates in Medicine (Medical College of Wisconsin, 1994) and Physical Chemistry (University of Wisconsin-Madison, 1983), with advanced training in nephrology and internal medicine at MCW-affiliated hospitals.

Dr. Wesson’s research focuses on calcium oxalate kidney stone pathogenesis, combining clinical and basic science approaches. Key areas include proteomic analysis of kidney stone matrices, protein-crystal interactions, and translational studies linking molecular mechanisms to stone formation. His work emphasizes identifying biomarkers and therapeutic targets through comparative proteomics and in vitro crystallization models.

His publications (2012–2025) consistently address kidney stone biochemistry, with recent studies exploring cat-human proteome comparisons and novel drug interventions. Though no formal grants or awards are listed, his prolific research output underscores sustained contributions to nephrology. Clinical interests include patient education and personalized care for fluid/electrolyte disorders and end-stage kidney disease.